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Endosomal trafficking is regulated by the recruitment of effector proteins to phosphatidylinositol 3-phosphate
[PtdIns(3)P] on early endosomes. At the plasma membrane, phosphatidylinositol-(3,4)-bisphosphate [PtdIns(3,4)P2] binds
the pleckstrin homology (PH) domain-containing proteins Akt and TAPP1. Type I␣ inositol polyphosphate 4-phosphatase
(4-phosphatase) dephosphorylates PtdIns(3,4)P2, forming PtdIns(3)P, but its subcellular localization is unknown. We
report here in quiescent cells, the 4-phosphatase colocalized with early and recycling endosomes. On growth factor
stimulation, 4-phosphatase endosomal localization persisted, but in addition the 4-phosphatase localized at the plasma
membrane. Overexpression of the 4-phosphatase in serum-stimulated cells increased cellular PtdIns(3)P levels and
prevented wortmannin-induced endosomal dilatation. Furthermore, mouse embryonic fibroblasts from homozygous
Weeble mice, which have a mutation in the type I 4-phosphatase, exhibited dilated early endosomes. 4-Phosphatase
translocation to the plasma membrane upon growth factor stimulation inhibited the recruitment of the TAPP1 PH domain.
The 4-phosphatase contains C2 domains, which bound PtdIns(3,4)P2, and C2-domain-deletion mutants lost PtdIns(3,4)P2
4-phosphatase activity, did not localize to endosomes or inhibit TAPP1 PH domain membrane recruitment. The 4-phosphatase therefore both generates and terminates phosphoinositide 3-kinase signals at distinct subcellular locations.

INTRODUCTION
Phosphoinositides generated by phosphoinositide 3-kinases
(PI 3-kinases) regulate cell survival, proliferation, migration,
and vesicular trafficking (Cantley, 2002; Czech, 2003). In agonist-stimulated cells, phosphatidylinositol-3,4,5-trisphosphate
[PtdIns(3,4,5)P3] is a transient plasma membrane (PM) signal,
rapidly hydrolyzed to phosphatidylinositol-(3,4)-bisphosphate
[PtdIns(3,4)P2] by the inositol polyphosphate 5-phosphatases
(5-phosphatases) (Stephens et al., 1993; Mitchell et al., 2002).
PtdIns(3,4)P2 is a more sustained signal lasting for up to 60
min, stimulated by B-cell activation, oxidative stress, or irreversible platelet aggregation (Banfic et al., 1998; Van der Kaay
et al., 1999; Marshall et al., 2002).
PtdIns(3,4,5)P3 effectors include proteins with pleckstrin
homology (PH) domains such as the serine/threonine ki-
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nases Akt and PDK1; the Tec family of tyrosine kinases;
various adapter proteins; and exchange factors for small
GTPases (Czech, 2003; Lemmon, 2003). PtdIns(3,4)P2 recruits
and activates an overlapping and distinct subset of effector
proteins relative to PtdIns(3,4,5)P3. For example, Akt, a key
regulator of apoptotic and insulin signaling, contains a PH
domain that in vitro binds both PtdIns(3,4,5)P3 and
PtdIns(3,4)P2 with comparable affinity (Lemmon, 2003). Both
PtdIns(3,4,5)P3 and PtdIns(3,4)P2 are required for the full in
vivo activation of Akt (Scheid et al., 2002). The PH domain of
the dual adaptor for phosphotyrosine and 3-phosphoinositides (DAPP1) binds both PtdIns(3,4,5)P3 and PtdIns(3,4)P2
(Ferguson et al., 2000), whereas the PX domain of p47phox
binds both PtdIns(3,4)P2 and PtdIns(3)P (Kanai et al., 2001).
Specific PtdIns(3,4)P2 binding proteins, the tandem PH-domain– containing proteins TAPP1 and TAPP2, have been
characterized recently (Dowler et al., 2000).
PtdIns(3,4)P2 is hydrolyzed to form PtdIns(3)P by the
inositol polyphosphate 4-phosphatases, but the intracellular
site of this reaction remains to be determined. Furthermore,
it is unknown whether the PtdIns(3)P generated by the
4-phosphatase contributes to a functional PtdIns(3)P pool at
the PM or other intracellular membranes. Two human
4-phosphatase isoforms (type I and II) have been identified,
sharing 37% amino acid identity. Both isoforms contain a
catalytic “CX5R” motif found in both protein tyrosine phosphatases and dual specificity protein/lipid phosphatases.
(Norris et al., 1995, 1997a). The type I␣ 4-phosphatase regulates megakaryocyte cell growth, acting downstream of the
transcription factor GATA-1. Overexpression of this 4-phos© 2005 by The American Society for Cell Biology
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phatase in NIH 3T3 fibroblasts suppresses cellular proliferation, without affecting apoptosis (Vyas et al., 2000). A spontaneous mutant mouse (Weeble), which has a phenotype of
neuronal loss in the cerebellum/hippocampus, severe
ataxia, and neonatal death, has been identified and is associated with mutation in the type I 4-phosphatase gene (Nystuen et al., 2001).
In this study, we show that the type I 4-phosphatase
localizes to endosomal membranes, generating PtdIns(3)P
via hydrolysis of PtdIns(3,4)P2, thereby rescuing the phenotype of wortmannin-induced endosomal dilatation. After
epidermal growth factor (EGF) stimulation, the 4-phosphatase translocates to the PM and inhibits the PM recruitment
of the TAPP1 PH domain. The 4-phosphatase contains an
N-terminal tandem C2 domain that is essential for catalytic
activity, endosomal localization, and regulation of the recruitment of effectors with PtdIns(3,4)P2-specific PH domains to the PM. The 4-phosphatase hence functions in both
generating PtdIns(3)P on endosomal membranes and terminating PtdIns(3,4)P2 signals at the PM.
MATERIALS AND METHODS
General Reagents and Vectors
Restriction and DNA-modifying enzymes were from New England Biolabs
(Beverly, MA), Fermentas (Hanover, MD), or Promega (Madison, WI). Big dye
terminator cycle sequencing was from PerkinElmer Life and Analytical Sciences (Boston, MA), synthetic peptides were from Chiron Mimotopes (Clayton, Australia), [␥-32P]ATP was from PerkinElmer Life and Analytical Sciences, phospholipids were from BIOMOL Research Laboratories (Plymouth
Meeting, PA), oligonucleotides were from Monash University (Clayton, Australia), pTrcHisC vector was from Invitrogen (Carlsbad, CA), pGEX-KG was
from American Type Culture Collection (Manassas, MD), and pEGFP-C2 was
from BD Biosciences Clontech (Palo Alto, CA). pEFBOS-FLAG vector was
from Dr. Willson (Walter and Eliza Hall Institute, Melbourne, Australia).
Rab5 and Rab5Q79L cDNAs were kindly provided by Dr. R. Parton (University of Queensland, Brisbane, Australia). The PH domain of TAPP1 (aa
95– 404) cDNA was from Dr. S. Dowler (MRC Protein Phosphorylation Unit,
University of Dundee, Dundee, United Kingdom). Other reagents were from
Sigma-Aldrich (St. Louis, MO).

Antibodies
Two New Zealand White rabbits were immunized with the 4-phosphatase
type I peptides (1MTAREHSPRHGARARA16C and 174EEKSDQRPPVTRSVDTVNGR193C) conjugated via the terminal cysteine to diphtheria toxoid.
Serum was purified on an immunopeptide-coupled thiopropyl-Sepharose 6B
resin. Other antibodies or stains were obtained as indicated: Xpress antibody
(Invitrogen); FLAG antibody (Sigma-Aldrich); hemagglutinin (HA) antibody
(Silenus, Melbourne, Australia); green fluorescent protein (GFP) antibody, phalloidin, and Alexa Fluor-conjugated secondary antibodies (Molecular Probes, Eugene, OR); glutathione S-transferase (GST) antibody (Promega); ␤-tubulin, ␥-adaptin, and ␤-COP, Rab11 antibody (Zymed Laboratories, South San Francisco, CA); Rab8 (BD Biosciences, San Jose, CA), LAMP-2
antibody (Developmental Studies Hybridoma Bank, University of Iowa, Iowa
City, IA); and human early endosomal antigen (EEA)-1 antibody (gift from
Dr. B. Hok-Toh, Monash University).

Purification of Recombinant 4-Phosphatase
Human 4-phosphatase type I sequence was PCR amplified and subcloned
into the KpnI site of pTrcHisC (pTrcHisC-4ptase) or the HindIII site of
pGEX-KG (pGEX-KG-4ptase), adding N-terminal hexa-His and GST tags in
frame. Asp693 was PCR mutated to asparagine and ligated into the KpnI site
of pTrcHisC (pTrcHis-D693N). N-terminal GST-tandem C2 domains were
PCR amplified and subcloned into the pGEX-KG HindIII site. 4-Phosphatase
(aa 305–939) was PCR amplified and subcloned into the KpnI site of pTrcHisC
or into the HindIII site of pGEX-KG (pTrcHis-4ptase⌬C2AB and pGEX-KG4ptase⌬C2AB). Constructs were transformed into BL21 Escherichia coli, incubated to an OD600 ⫽ 0.6, and protein was induced with isopropyl ␤-dthiogalactopyranoside (1 mM final). Pelleted bacteria were resuspended in 50
mM Tris, pH 8, 1 M NaCl, protease inhibitor cocktail (Roche Diagnostics,
Indianapolis, IN) lysed by 3⫻ sonication 30 s on ice, pelleted 19,000 ⫻ g (15
min) and purified by Ni2⫹ affinity chromatography. Ni-NTA resin (2 ml) (BD
Biosciences, Palo Alto, CA), preequilibrated with lysis buffer, was added to
the cleared bacterial lysate and rocked at 4°C 1 h, pelleted at 700 ⫻ g for 5 min,
washed, proteins eluted with 10 ml of 75 mM imidazole, 50 mM Tris, pH 8,
1 M NaCl, and concentrated using a Vivaspin 10,000 molecular weight cut-off
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(Vivascience, Stonehouse, United Kingdom). Two milliliters of glutathione
Sepharose resin, preequilibrated with phosphate-buffered saline (PBS), was
added to the cleared bacterial lysate, rocked at 4°C for 1 h, pelleted at 500 ⫻
g for 5 min, washed with ice-cold PBS, and eluted with 10 mM glutathione, 50
mM Tris, pH 8.

Mammalian Expression Plasmids
Wild-type 4-phosphatase cDNA was subcloned into pEGFP-C2 (KpnI site)
and pEFBOS (MluI site) encoding GFP- and FLAG-tagged 4-phosphatase,
respectively. The 4-phosphatase catalytic mutant C856S was PCR generated
and cloned into pEGFP-C2 (KpnI site) and pEFBOS (MluI site). Various
4-phosphatase mutants or domains were PCR amplified and subcloned into
the KpnI sites of pEGFP-C2, or pCGN and/or the MluI site of pEFBOS. All
PCR product sequences were confirmed by Big-Dye Terminator DNA sequencing.

Cell Culture, Transient Transfections, and Microscopy
COS-1 and Chinese hamster ovary (CHO) cells were cultured in DMEM and
Ham’s-F-12, respectively, with 10% fetal calf serum (FCS) (CSL Biosciences,
Parkville, Australia), 100 U/ml penicillin/streptomycin, and 2 mM glutamine. COS-1 cell transfections were performed by electroporation, using the
Gene Pulser II System (Bio-Rad, Hercules, CA). For confocal microscopy,
transfected cells were grown on coverslips and allowed to recover for 20 – 40
h. Nontransfected or transfected cells (24 h posttransfection) were serumstarved for 20 h and stimulated with 100 ng/ml EGF or grown in DMEM 10%
FCS, or Ham’s-F-12, or serum-starved for 1–2 h and incubated with nocodazole (30 mM for 45 min), or 100 nM wortmannin (for 30 min or 60 min), or
brefeldin A, and fixed with 3% paraformaldehyde and permeabilized with
0.2% Triton X-100. Primary antibodies were incubated for 45 min at room
temperature (RT) in the following dilutions: anti-EEA-1 (1:10,000); anti-FLAG
and anti-HA (1:2000); anti-Xpress (1:500); anti-␤-tubulin, anti-␥-adaptin, and
anti-␤-COP (1:50); anti-Rab11, anti-Rab8, and anti-LAMP2 (1:20); and anti-4phosphatase (1:5). Antibodies were detected using Alexa-conjugated goat
anti-mouse or mouse anti-rabbit secondary antibodies (1:800). Coverslips
were washed three times with PBS and mounted onto glass slides by using
SlowFade. Single plane or stacked images were obtained using a Leica
TCS-NT Krypton or Fluroview confocal microscope.
For ultrastructural analysis of 4-phosphatase localization by using electron
microscopy, CHO cells were transiently cotransfected with GFP-4-phosphatase and human transferrin receptor (hTfnR), incubated with 25 g/ml Tfnhorseradish peroxidase (HRP), and Tfn-positive endosomes were labeled
with the electron-dense peroxidase 3,3⬘-diaminobenzidine (DAB) reaction
product. Ultrathin cryosections were incubated with GFP antibody followed
by 10-nm gold-conjugated anti-mouse IgG secondary antibody.

Preparation of Cell Lysates
Cell lines grown to confluence were washed with PBS, lysed in 50 mM Tris,
pH 8.0, 150 mM NaCl, 1% Triton X-100, 2 mM EDTA, 1 mM benzamidine, 2
mM phenylmethylsulfonyl fluoride, 2 g/ml leupeptin, and 2 g/ml aprotinin for 2 h at 4°C, and pelleted at 15,400 ⫻ g (10 min) to isolate the
Triton-soluble fraction.

Lipid 4-Phosphatase Assays
PtdIns[32P-3,4]P2 was formed by incubating 56 g of PtdIns(4)P with 20 g of
phosphatidylserine (PtdSer), 1 g of recombinant PI 3-kinase (Layton et al.,
1998), 50 M ATP, 20 l of [␥-32P]ATP (0.2 mCi, 3000 Ci/mM; MP Biomedicals, Irvine, CA), and 5 l of 20⫻ kinase buffer (400 mM Tris, pH 7.4, 100 mM
MgCl2, and 10 mM EGTA) in 100 l. Lipid products were extracted and
suspended in 20 mM Tris, pH 7.4, 1 mM EGTA. Lipid 4-phosphatase assays
(100 l) were performed by adding PtdIns[32P-3,4]P2 to the recombinant
wild-type or mutant 4-phosphatase in 50 mM 3-(N-morpholino)propanesulfonic acid, 10 mM EDTA, and 200 mM NaCl at 37°C for 30 min. Extracted
lipids were analyzed by thin-layer chromatography (TLC) in chloroform/
methanol/acetic acid/water [43:38:5:7 (vol/vol)]. Phosphoinositide products
were excised from the TLC and counted using liquid scintillation counting.

Liposome Binding Assays
Phosphatidylethanolamine with PtdSer, PtdIns3P, PtdIns4P, PtdIns(3,4)P2, or
PtdIns(4,5)P2 at a 5% molar ratio mixture was dried under N2 and resuspended in 20 mM HEPES, pH 7.2, 100 mM NaCl, and 500 M EDTA;
sonicated (5 min) to form liposomes; incubated with GST-fusion proteins in 50
l of sample buffer for 10 min at RT; and pelleted at 100,000 ⫻ g for 30 min.
The pellet was resuspended in 35 l of SDS-PAGE reducing buffer, analyzed
by 10% SDS-PAGE, and silver stained. Densitometry was performed using
GelPro software (Media Cybernetics, Silver Spring, MD).

Determination of Phosphoinositide Levels in Cells
Overexpressing 4-Phosphatase I
A T-Rex tetracycline-regulated system (Invitrogen) was used to create cell
lines stably overexpressing 4-phosphatase-1 as described previously
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Figure 1. 4-Phosphatase intracellular localization. (A) Triton-soluble fraction of cell lysates from the indicated cell lines or COS-1 cells
expressing FLAG-tagged wild-type 4-phosphatase, or the N-terminal 304 aa, were immunoblotted with affinity-purified 4-phosphatase
antibody. (B) Serum-starved CHO cells were stained with affinity-purified 4-phosphatase antibody (left). COS-1 cells transiently expressing
GFP-tagged wild-type (middle) or inactive 4-phosphataseC856S (right) were visualized by confocal microscopy, or lysates were immunoblotted with GFP antibody. Bar, 5 m.

(Kisseleva et al., 2002), by using 293T-Rex cells (Invitrogen). Addition of
100 ng of tetracycline per milliliter to the growth medium induced the
expression of the 4-phosphatase. Cells were labeled in 35-mm tissue culture dishes in 1 ml of medium containing 400 Ci of [32P]orthophosphate
(PerkinElmer Life and Analytical Sciences) for 2– 4 h at 37°C in a phosphate-free DMEM (Invitrogen) containing 5% FCS dialyzed against 0.85%
NaCl. Cells were harvested, spun, and lysed by an addition of 1.8 ml of
methanol/chloroform/8% HClO4 (20:10:1). Lipids were extracted by the
addition of 500 l of chloroform and 500 l of 1% HClO4, and the lower
organic phase was collected, washed twice with 1% HClO4, and evaporated. Deacylation was as described previously (Caldwell et al., 1991).
Glycerophosphorylinositol derivatives were resolved on an anion-exchange column (PartiSphere Sax, 4.6 ⫻ 125 mm; Whatman, Maidstone,
United Kingdom) by using a 0 –1.25 M NaH2PO4, pH 4.5, gradient as
described previously (Kisseleva et al., 2002). Radiolabeled deacylated
phospholipids were detected by a ␤-RAM in-flow detection system
(IN/US Systems, Tampa, FL). Data were normalized to the total 32P counts
in PtdIns(4)P, which were stable in all cell lines regardless of construct
expressed, accounting for 10% of [32P]orthophosphate incorporated.

Isolation of Mouse Embryonic Fibroblasts (MEFs)
MEFs were isolated from 12.5-d-old embryos from a heterozygous Weeble
mouse mating (The Jackson Laboratory, Bar Harbor, ME). These cells were
expanded for two passages before analysis by immunofluorescent confocal
microscopy, which was performed as described above. Lysates from MEFs
were immunoblotted using a previously described C-terminal 4-phosphatase
antibody (Norris et al., 1997b). Genotyping of MEFs was performed as described previously (Nystuen et al., 2001).
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RESULTS
4-Phosphatase Localizes to Intracellular Vesicles in
Quiescent Cells
To investigate the intracellular localization of the type I
4-phosphatase, we developed antipeptide antibodies to two
4-phosphatase peptide sequences (aa 1–16 and 174 –193),
which showed no identity to any sequences in the protein
databases. The antibody immunoblotted FLAG-4-phosphatase and the N-terminal domain (aa 1–304) to which the
antibody was raised (Figure 1A). Moreover, this peptide
affinity-purified antibody detected a 105-kDa polypeptide in
human embryonic kidney 293, CHO, HL60 (myeloid), U937
(promonocytic), MEG-01 (megakaryocytic), and faintly in
PC12 (neuroendocrine) cells, consistent with the endogenous enzyme (Figure 1A).
The intracellular localization of endogenous 4-phosphatase was determined in serum-starved CHO cells by indirect
immunofluorescence, by using anti-4-phosphatase antibodies, which labeled distinct punctate vesicles throughout the
cytosol, reminiscent of endocytic organelles (Figure 1B, left).
Preimmune serum was nonreactive (our unpublished data).
GFP-tagged-wild-type or catalytically inactive 4-phosphataseC856S, which contains a C-S mutation in the CX5R cataMolecular Biology of the Cell
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lytic site resulting in complete loss of enzyme activity (Norris et al., 1997a), was expressed in COS-1 cells (Figure 1B,
middle and right, respectively). GFP-tagged 4-phosphatase
localized in a perinuclear distribution, with punctate vesicular and faint cytosolic staining. A similar distribution was
noted when the 4-phosphatase was expressed with a FLAG
tag (our unpublished data). Cytosolic staining was more
prominent in cells overexpressing the 4-phosphatase at high
levels. The catalytically inactive mutant, whether expressed
with an N-terminal GFP, or FLAG-tag (our unpublished
data), demonstrated vesicular and faint cytosolic staining,
with less prominent vesicle clustering noted in the perinuclear region than for the wild-type enzyme (Figure 1B). In
control studies, GFP- and FLAG-tagged (our unpublished
data) wild-type and catalytically inactive 4-phosphatase
polypeptides were expressed without significant proteolysis
(Figure 1B). The structural integrity of Golgi cisternae, endosomal compartments, and lysosomes is maintained by
tethering of these organelles to microtubules emanating
from the microtubule-organizing center (MTOC) (Matteoni
and Kreis, 1987). On nocodozole treatment, the MTOC collapsed and microtubules dispersed (evident on costaining
with anti-␤-tubulin), correlating with cytosolic redistribution of 4-phosphatase– decorated vesicles (our unpublished
data). In cells treated with dimethyl sulfoxide vehicle alone,
4-phosphatase perinuclear staining persisted, overlapping
with the MTOC (our unpublished data). The 4-phosphatase
therefore localizes to microtubule-tethered vesicles and its
overexpression may promote vesicle clustering in the perinuclear region.
4-Phosphatase Colocalizes with Early and Recycling
Endosomes in Quiescent Cells
The subcellular localization of the 4-phosphatase was determined by colocalization of GFP- or FLAG-4-phosphatase
with specific endocytic or secretory markers (Figure 2, A–C).
A significant proportion of 4-phosphatase-positive vesicles
colocalized with the EEA-1 (Figure 2A, a, arrows in merged
image). FLAG-4-phosphatase also colocalized extensively
with GFP-Rab5 (Figure 2A, b, arrows in merged image).
Rab11 is a small GTPase that localizes to perinuclear recycling endosomes and the trans-Golgi network (Ren et al.,
1998). GFP-4-phosphatase– decorated vesicles colocalized
with both recombinant XPRESS-tagged and endogenous
Rab11, most intensely in the perinuclear region (Figure 2A,
c and d, arrow in merged images).
The colocalization of the 4-phosphatase with the hTfnR
was performed at an ultrastructural level. The TfnR
traverses the entire endocytic pathway from early/sorting to
perinuclear recycling endosomes and back to PM (Maxfield
and McGraw, 2004). CHO cells were transiently cotransfected with GFP-4-phosphatase and hTfnR, incubated with
25 g/ml Tfn-HRP and Tfn-positive endosomes labeled
with the electron-dense peroxidase DAB reaction product
(Stoorvogel et al., 1996). Ultrathin cryosections were incubated with an anti-GFP antibody followed by 10-nm goldconjugated anti-mouse IgG secondary antibody (Figure 2B).
GFP-4-phosphatase– decorated clusters of tubulo-vesicular
structures, ⬃100 nm in diameter, which were DAB and
hence Tfn positive. In addition 4-phosphatase-labeled vesicles were detected as densely staining DAB-positive vesicle
clusters in the peri-Golgi region (Figure 2B, a, box, which is
magnified in b). The 4-phosphatase–stained vesicles were
not surrounded by an outer membrane and were hence
distinct from multivesicular bodies (Figure 2B, b). The striking colocalization of the 4-phosphatase with Tfn-positive
structures suggests it localizes to early and recycling endoVol. 16, May 2005

somes. In control studies, gold particles were not detected
using isotype IgG1 antibodies to tyrosine hydroxylase (Figure 2B, c).
No colocalization of the 4-phosphatase was demonstrated
with Rab7 (late endosome/lysosome), LAMP-2 (lysosome),
or mannose 6-phosphate receptor (M6PR) (Golgi to lysosome) (Figure 2C), or with the markers of the constitutive
secretory pathway as shown by coexpression with GFPtagged temperature-sensitive mutant of vesicular stomatitis
virus glycoprotein (our unpublished data). Furthermore, the
4-phosphatase did not colocalize with endogenous Rab8, a
marker of secretory vesicles (Figure 2C). 4-Phosphatase–
expressing cells also were stained with antibodies to the
Golgi-specific markers ␤-COP (Figure 2C, bottom), ␥-adaptin and Rab6a (our unpublished data), but no colocalization
was observed. Moreover, 4-phosphatase perinuclear localization remained unperturbed after brefeldin A-induced
Golgi collapse (our unpublished data). Collectively, these
studies demonstrate that in quiescent cells, the 4-phosphatase colocalizes most consistently with markers of early and
recycling endosomal compartments.
4-Phosphatase Accumulates on Early and Recycling
Endosomes upon Expression of Specific Rab GTPase
Mutants
We examined 4-phosphatase localization upon coexpression
with specific Rab GTPase mutants. Rab5 regulates clathrincoated vesicle formation, endosome motility, and early endosome fusion (Smythe, 2002). Overexpression of the
GTPase-deficient Rab5 mutant, Rab5Q79L, causes enlargement of early endosomes, resulting from enhanced homoand heterotypic fusion (Barbieri et al., 1996). Under these
conditions, the 4-phosphatase colocalized significantly with
the enlarged Rab5Q79L-positive vesicles (Figure 3). Rab7
facilitates the correct aggregation and fusion of late endocytic structures and the biogenesis of lysosomes. Overexpression of the active GFP-Rab7Q67L causes enlargement
and increased aggregation of late endocytic vesicles in the
perinuclear region (Bucci et al., 2000). No significant colocalization between Rab7-decorated vesicles and the 4-phosphatase was apparent (Figure 3). Overexpression of Rab11Q70L,
a dominant-positive GTPase-deficient mutant, increases the
rate of Tfn uptake and accumulation of TfnR in early endosomes, as well as enhancing perinuclear recycling and inhibiting endosome to TGN trafficking (Wilcke et al., 2000).
The GDP-locked mutant, Rab11S25N, localizes to the cytosol
as GTP hydrolysis is required for recruitment of Rab11 and
its effectors to endosomal membranes (Wilcke et al., 2000). In
cells overexpressing Rab11S25N, the 4-phosphatase showed
a more prominent cytosolic distribution with loss of endosomal
localization (Figure 3). When coexpressed with Rab11Q70L, the
4-phosphatase colocalized with Rab11Q70L-positive vesicles
(Figure 3). Interestingly, under these conditions the 4-phosphatase also localized to the PM in quiescent cells (Figure 3, row 4,
arrow), suggesting that this constitutively active Rab11 mutant
may promote the recycling of 4-phosphatase-decorated vesicles to the PM. In control studies, no change in the localization
of EEA-1 (early endosomes) or Sec15 (recycling endosomes)
(Zhang et al., 2004) was observed upon expression of
Rab11Q70L (Figure 3, bottom two rows). This demonstrates
that the 4-phosphatase may associate with and/or dissociate
from early/recycling endosomes upon overexpression of specific Rab GTPase mutants.
2221
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Figure 2. 4-Phosphatase colocalizes with endosomes. (A) COS-1 cells expressing GFP-4-phosphatase (green) or FLAG-4-phosphatase (row
2, red) were serum-starved overnight and colocalized with EEA-1 (a, red) or Rab11 (d, red) by using specific antibodies, or recombinant
Xpress-Rab11 (c, red) or GFP-Rab5 (b, green), and visualized by confocal microscopy. Merged images are shown on the right. Arrows indicate
colocalization. Cells were serum-starved overnight before fixation. Bar, 5 m. (B) CHO cells expressing GFP-4-phosphatase and human TfnR
were incubated with 25 g/ml Tfn-HRP for 30 min at 37°C and subjected to DAB cytochemistry. Ultrathin cryosections were incubated with
GFP antibody and gold particle-conjugated anti-mouse IgG secondary antibody. (a) Low-power electron micrograph with DAB-positive/
gold-labeled tubulo-vesicular structures (see arrows and boxed region). (b) High-power electron micrograph of boxed region in a. (c)
High-power electron micrograph of vesicle clusters by using an anti-tyrosine hydroxylase IgG1 isotype control, showing DAB-positive
regions with no immunogold labeling. n, nucleus. Bar, 1 m. (C) COS-1 cells were either cotransfected with wild-type 4-phosphatase and
Xpress-Rab7, or GFP-M6PR and serum-starved overnight. 4-Phosphatase– expressing cells were costained for endogenous lysosome (antiLamp-2), Golgi (anti-␤-COP), or secretory vesicle (anti-Rab8) markers. All cells were serum-starved overnight before fixation. Bar, 5 m.

4-Phosphatase Translocates to the Plasma Membrane
upon EGF Stimulation
EGF treatment stimulates PtdIns(3,4)P2 synthesis at the PM
(Cantley, 2002), and under these conditions, within 5 min,
both the endogenous (our unpublished data) and the recombinant 4-phosphatase (Figure 4A, arrows) were detected at
2222

the PM persisting up to 30 min in the majority of cells (⬎300
cells scored from three independent transfections). In addition we noted 4-phosphatase endosomal localization persisted in EGF-stimulated cells. The 4-phosphatase colocalized with areas of intense actin staining at the leading edge
of the EGF-stimulated cells (membrane ruffles), as shown by
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Figure 3. 4-Phosphatase localization upon expression of Rab GTPase mutants. COS-1 cells were cotransfected with wild-type 4-phosphatase
and Rab5Q79L, Rab7Q67L, dominant-negative Rab11 (Rab11S25N), or Rab11Q70L; serum-starved overnight; and visualized by confocal
microscopy. Arrow shows 4-phosphatase PM localization upon coexpression with Rab11Q70L. Control studies in Rab11Q70L-expressing
cells demonstrate unchanged EEA1 (early endosome) and Sec15 (recycling endosome) localization. Merged images are shown on the right
in top three panels only. Bar, 5 m.
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Figure 4. EGF stimulates 4-phosphatase
plasma membrane translocation. COS-1 cells
transiently expressing GFP-4-phosphatase
(A) were serum-starved overnight, stimulated with 100 ng/ml EGF, fixed, counterstained with phalloidin, and visualized by
confocal microscopy. Arrow indicates GFP4-phosphatase plasma membrane localization. (B) COS-1 cells expressing GFP-4-phosphatase were serum-starved overnight and
treated with 30 M nocodazole for 45 min,
washed, and stimulated with 100 ng/ml
EGF for 10 min and counterstained with anti-␤-tubulin monoclonal antibody. Merged
images are shown on the right. Bar, 5 m.

phalloidin staining (Figure 4A). Minimal colocalization of
the 4-phosphatase was demonstrated with actin stress fibers,
either in quiescent or stimulated cells. Notably, in cells over2224

expressing the recombinant 4-phosphatase, after EGF stimulation, no decrease in the number of membrane ruffles
formed was detected relative to empty vector-expressing
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Figure 5. Type I 4-phosphatase domain organization. 4-Phosphatase domains and
summary of constructs which are NH2-terminally His6, GST, FLAG, HA, or GFP
tagged. Shown also are the residues critical
for catalysis, including D693 and C856.

cells. Depolymerization of microtubules upon nocodozole
treatment resulted in complete abrogation of 4-phosphatase
translocation to the PM, indicating that 4-phosphatase PM
translocation is microtubule dependent (Figure 4B).
4-Phosphatase Contains an N-Terminal Tandem C2
Domain
The human type I 4-phosphatase sequence (GENPEPT
[NP_004018]) was used as a probe in PSI-BLAST searches
(Altschul et al., 1997) and showed significant sequence similarity (expect score 3 ⫻ 10⫺27) in the N terminus (residues
31–206) to the synaptotagmin tandem C2 domains (C2A/
C2B) (pdb identifier 1DQV) (Bai and Chapman, 2004) and
similarity to numerous other C2 domains (expect score 3 ⫻
10⫺27) (Hurley and Meyer, 2001). The 4-phosphatase central
domain (residues 305– 608) seems unique, sharing no sequence similarity to other protein families. The C-terminal
catalytic domain has been defined previously (Norris et al.,
1997b). Based on these data and the structural analysis of the
synaptotagmin tandem C2 domains, we propose that the
N-terminal region of the human type I 4-phosphatase (residues 1–151) contains a C2 domain (C2A), and we predict
that a second, tandem C2 domain (C2B) is located between
residues 156 –304 (Figure 5). The extent of sequence similarity is low (⬍15%) within the second putative C2 domain,
and accurate assignment of domain boundaries based upon
informatics data alone is difficult. A variety of 4-phosphatase
constructs were developed to functionally assign individual
regions that regulate enzyme activity and/or subcellular
localization (Figure 5). Structural studies of PTEN and tyVol. 16, May 2005

rosine phosphatases reveal that the catalytic CX5R motif
forms a tight loop that binds the substrate’s phosphate moiety and contains the catalytic cysteine responsible for the
nucleophilic attack (Lee et al., 1999; Das et al., 2003). In
addition, a conserved aspartic acid (Asp) located on a mobile
loop N-terminal to the catalytic cysteine acts as a general
acid essential for catalytic activity. We have identified a
conserved candidate Asp residue in all 4-phosphatases, including the archeal SopB and SigD, as D693 (Figure 5),
(Norris et al., 1998).
To characterize the role of the C2 domains and/or candidate catalytic Asp (D693) in PtdIns(3,4)P2 hydrolysis, we
generated wild-type and mutant 4-phosphatases that lacked
the N-terminal tandem C2 domain (⌬C2AB) or had a mutation in D693 (D693N) (Figure 5). His-tagged wild-type
4-phosphatase, D693N-4-phosphatase, and a mutant lacking
the C2AB domain (⌬C2AB) were expressed and purified
(Figure 6A). Recombinant wild-type 4-phosphatase dephosphorylated PtdIns[32P-3,4]P2 forming PtdIns[32P-3]P. However, mutation of the conserved Asp, D693N, resulted in
complete loss of lipid phosphatase activity at all enzyme
concentrations tested (Figure 6B). Despite the presence of
this essential catalytic Asp and the Cx5R motif, characteristic
of tyrosine phosphatases, the 4-phosphatase exhibited no
tyrosine phosphatase activity (our unpublished data). Recombinant 4-phosphatase which lacked the tandem C2 domain (4-phosphatase⌬C2AB) showed little PtdIns(3,4)P2
4-phosphatase activity, suggesting that this domain may
significantly regulate either substrate binding and/or sub2225
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strate orientation with respect to the catalytic domain (Figure 6B).
4-Phosphatase C2AB Domain Binds to Phosphoinositides
In Vitro
We investigated the potential role of the tandem C2 domain
in PtdIns(3,4)P2 binding, given that the 4-phosphatase C2
domain deletion mutants lose catalytic activity. Liposomal
binding studies were undertaken to examine the interaction
of the C2AB domains versus the catalytic domain with
PtdIns(3,4)P2 and the 4-phosphatase reaction product
PtdIns(3)P. GST-C2AB bound PtdIns(3,4)P2 and to a lesser
extent phosphatidylserine, but failed to bind PtdIns(3)P,
although it could bind other monophosphorylated phosphoinositides such as PtdIns(4)P (Figure 6C). A 4-phosphatase mutant that contains the catalytic domain, but not the
C2AB domain (⌬C2AB), bound both PtdIns(3,4)P2 and
PtdIns (3)P (Figure 6D). In control studies, GST did not bind
any phospholipids (our unpublished data). Thus, both the
C2AB domain and the catalytic domain facilitate
PtdIns(3,4)P2 binding, whereas the catalytic domain also
binds the product of 4-phosphatase PtdIns(3,4)P2 hydrolysis, PtdIns(3)P. C2AB domain binding to PtdIns(3,4)P2 may
contribute to 4-phosphatase substrate orientation with respect to residue D693 and thus facilitate PtdIns(3,4)P2 D4
phosphate hydrolysis.
4-Phosphatase C2AB Domain Mediates Endosomal
Localization
We investigated the subcellular targeting of the 4-phosphatase by specific domains. The individual C2A or C2B domains localized diffusely in the cytosol (Figures 7A and 5,
for constructs). However, the C2AB domain showed distinct
vesicular staining with little cytosolic distribution. These
vesicles colocalized with Rab11 (our unpublished data).
4-phosphatase mutants lacking the C2A, or the C2AB domain (⌬C2A and ⌬C2AB, respectively) showed predominantly cytosolic staining. A 4-phosphatase mutant lacking
the C-terminal half of the catalytic domain (⌬1/2 catalytic)
localized to endosomal vesicles and the cytosol like the
intact wild-type 4-phosphatase but without the prominent
perinuclear vesicle clustering. The catalytic domain localized diffusely in the cytosol and the perinuclear region, but
endosomal vesicles were not as clearly delineated. Hence,
the C2 domains play a significant role in directing the
4-phosphatase to endosomes. Immunoblot analysis showed
intact expression of all mutants (Figure 7A).
We also investigated which 4-phosphatase domain directs
PM localization. After EGF stimulation (10 min), the isolated
C2AB domain was not detected at the PM; however, the
addition of the central domain to the C2AB domain (C2AB
⫹ central) resulted in prominent PM localization, suggesting
that this central domain contains critical motifs that facilitate
PM targeting (Figure 7B, arrow). Mutant 4-phosphatase
lacking either the C2A domain (⌬C2A) or both the N-terminal C2 domains (⌬C2AB) showed PM recruitment (Figure
7B, arrow). The isolated 4-phosphatase catalytic domain also
localized to the PM on EGF stimulation (Figure 7B, arrow).
Therefore, 4-phosphatase PM relocalization is facilitated by
the catalytic and central but not the C2AB domains.
Expression of the Catalytically Active 4-Phosphatase
Rescues the Wortmannin-induced Dilatation of Early
Endosomes
The studies reported here have revealed a previously unrecognized localization of the 4-phosphatase to endosomes.
PtdIns(3)P is synthesized on early endosomes by the wort2226

Figure 6. Phosphoinositide binding of 4-phosphatase domains. (A)
Purified His6-tagged wild-type, catalytically inactive 4-phosphatase
(D493N), or 4-phosphatase lacking the C2AB domain (4-phosphatase
⌬C2AB) were immunoblotted with anti-His6 antibodies. (B) Hydrolysis of PtdIns[32P-3,4]P2 by the recombinant wild-type 4-phosphatase
(24 –120 g) or the indicated mutants. Extracted lipids were analyzed
by TLC and autoradiography and compared with the migration of
known standards. (C and D) Liposomes containing phosphatidylethanolamine/PtdSer and PtdIns3P, PtdIns4P, PtdIns(3,4)P2, or
PtdIns(4,5)P2 (500 M) were mixed with GST-C2 domains (C) or GSTcatalytic domain (D), and binding studies were performed as described
under Materials and Methods. Data are the mean and SE of four assays.
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Figure 7. 4-Phosphatase endosomal targeting by the C2 domain. COS-1 cells expressing the indicated constructs were serumstarved overnight (A) and stimulated with
100 ng/ml EGF for 10 min (B), fixed, and
stained with HA or FLAG antibodies, and
visualized by confocal microscopy. Arrows
in B indicate PM localization. Triton-soluble
extracts of transfected cell lysates were immunoblotted with either FLAG, HA, or GFP
antibodies (A). Molecular weight markers
are shown on the left.

mannin-sensitive PI3-kinase hVPS34, which is recruited to
endosomal membranes by Rab5GTP (Christoforidis et al.,
1999). Several studies have proposed that PtdIns(3)P regulates early endosomal fusion, because inhibition of PI3-kinase activity by using the inhibitor wortmannin is associated
with early endosomal dilatation and inhibition of in vitro
early endosomal fusion (Jones and Clague, 1995; Li et al.,
1995; Jones et al., 1998). EEA-1 localizes to early endosomal
membranes, by an interaction between its FYVE domain,
PtdIns(3)P, and Rab5-GTP (Stenmark et al., 1996). Treatment
of cells with 100 nM wortmannin blocks PtdIns(3)P synthesis on early endosomes, leading to EEA-1 dissociation
(Patki et al., 1997), and the early endosomes become dilated,
looking like large, hollow rings (Simonsen et al., 1998).
Vol. 16, May 2005

PtdIns(3,4)P2 accumulates both at the plasma membrane
and on intracellular membranes, including tubulo-vesicular
structures, the endoplasmic reticulum, and multivesicular
bodies upon agonist stimulation (Watt et al., 2004). We reasoned that overexpression of the 4-phosphatase may catalyze the hydrolysis of PtdIns(3,4)P2, forming PtdIns(3)P on
endosomal membranes. The effect of 4-phosphatase overexpression on wortmannin-induced endosomal dilatation was
therefore examined. To this end, COS-1 cells, serum-starved
or grown in serum, the latter being the conditions under
which PtdIns(3,4)P2 levels increase (Figure 8, A and B, respectively), transiently expressing the wild-type or inactive
4-phosphataseC856S were treated with 100 nM wortmannin
(30 min) and counterstained with EEA-1 antibody. Serum2227
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Figure 8. 4-Phosphatase rescues the wortmannin-induced dilatation of early endosomes. COS-1 cells transiently expressing GFP-wild type
(A and B) or catalytically inactive (C856S) 4-phosphatase (C) were treated with 100 nM wortmannin for 30 min after serum starvation
overnight (A) or growth in serum (B and C) and were fixed and counterstained with EEA-1 antibody. White box in b is magnified in d; in
f, upper box is magnified in h; in f, lower box magnified in i; and box in k is magnified in m. Arrows indicate endosomal enlargement. Bar,
5 m. (D) Cells stably overexpressing the 4-phosphatase or empty vector were grown in serum and labeled for 2 h with [32P]orthophosphate.
Deacylated lipids were analyzed by SAX HPLC. 32P counts (cpm) derived from PtdIns(3,4)P2 or PtdIns(3)P for vector cells showing mean and
SE of three experiments (black bars); cells overexpressing type I 4-phosphatase showing mean and SE of four experiments (open bars).
PtdIns(3,4)P2 to PtdIns-3P ratios in vector versus type I 4-phosphatase– overexpressing cells are shown in boxed area.

starved, wortmannin-treated cells developed dilated early
endosomes in vector and inactive 4-phosphatase– expressing
cells (our unpublished data) and also upon overexpression
of the wild-type 4-phosphatase, as shown by the appearance
of dilated “EEA-1–stained rings” (Figure 8A, a– c, magnified
in d). Although EEA-1 dissociates from endosomal membranes upon wortmannin treatment, we found endosomal
EEA-1 staining was detected on dilated endosomes, consistent with reports that wortmannin-induced EEA-1 disassociation is incomplete in some cell lines (Chen and Wang,
2001; Tuma et al., 2001b). Notably, when grown in serum,
wortmannin-treated cells transiently overexpressing GFP-4phosphatase demonstrated normal-sized EEA-1– decorated
2228

endosomes (Figure 8B, magnified in h), whereas adjacent
nontransfected cells showed endosomal dilatation. (Figure
8B, magnified in i). Significantly, in cells grown in serum,
expression of the catalytically inactive 4-phosphataseC856S
did not rescue the wortmannin-induced dilatation of endosomes, and EEA-1– decorated endosomes looked dilated,
similar to nontransfected cells (Figure 8C, magnified in m).
No colocalization of the inactive 4-phosphatase C856S with
dilated endosomes was evident. Therefore, under serumstimulated conditions resulting in increased PtdIns(3,4)P2
synthesis, the 4-phosphatase may generate a PtdIns(3)P pool
on early endosomes, via the hydrolysis of its cognate substrate PtdIns(3,4)P2. Furthermore, given that wortmannin
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Figure 9. Type I 4-phosphatase ⫺/⫺ MEFs show endosomal dilatation. (A) Detergent-soluble fractions of MEFs were immunoblotted using
4-phosphatase (C-terminal) anti-peptide antibodies or ␤-tubulin antibodies as a loading control. (B) MEFs, ⫹/⫹ wild-type (WT), ⫹/⫺
heterozygotes, or homozygous ⫺/⫺ Weeble (Wbl) were stained with EEA-1 or Rab11 antibodies. The EEA-1–stained boxed area in a is shown
enlarged in ai, the boxed area in c is shown enlarged in ci. Rab11-stained boxed area in e is shown enlarged in ei; boxed area in g is shown
enlarged in gi. Arrows show endosomal dilatation. Bar, 5 m.

inhibits hVPS34-mediated synthesis of PtdIns(3)P on early
endosomes, the PtdIns(3,4)P2 pool hydrolyzed by the
4-phosphatase in wortmannin-treated cells may be synthesized by a wortmannin-resistant PI3-kinase, such as the class
II C2␣ PI 3-kinase (Domin et al., 2000).
We investigated whether the 4-phosphatase regulates the
total cellular levels of PtdIns(3)P by using stable cell lines
overexpressing this enzyme, generated using the T-Rex tetracycline-regulated system (Kisseleva et al., 2002). These
studies were performed on cells grown in serum, conditions
under which we demonstrated overexpression of the
4-phosphatase rescued the wortmannin-induced dilatation
of early endosomes. Deacylated 32P-labeled phosphoinositides were analyzed by anion-exchange high-performance liquid chromatography (HPLC). The levels of PtdIns(3,4)P2
and PtdIns(3)P are as shown in Figure 8D. In cells stably
transfected with type I 4-phosphatase, PtdIns(3,4)P2 was
reduced by 20% compared with the empty vector cells,
accompanied by a 1.76-fold increase in PtdIns(3)P. In vector
cells, the PtdIns(3)P/PtdIns(3,4)P2 ratio was 2.8 (Figure 8D),
whereas in cells overexpressing the 4-phosphatase, this ratio
increased to 6. In control studies, the levels of PtdIns(4)P and
PtdIns(4,5)P2 were comparable in vector and 4-phosphatase– overexpressing cells (our unpublished data). Therefore,
under conditions of serum stimulation, the total intracellular
levels of PtdIns(3)P are increased upon 4-phosphatase overexpression.
Vol. 16, May 2005

To further reveal whether the 4-phosphatase generates a
functional PtdIns (3)P pool, we examined the endosomes of
MEFs derived from homozygous Weeble mice (Nystuen et al.,
2001). The Weeble mutation was localized by genetic mapping to the 4-phosphatase type I gene. Deletion of a single
nucleotide 744G in the 4-phosphatase sequence, results in a
frame shift, creating a stop codon at aa 263. As anticipated,
4-phosphatase type I immunoblot analysis of cell lysates
from wild-type (WT), heterozygous, and homozygous
Weeble MEFs revealed the absence of the 105-kDa 4-phosphatase in Weeble ⫺/⫺ MEF lysates (Figure 9A). Wild-type
MEFs grown in serum demonstrated punctate EEA-1 staining of endosomes (Figure 9B, a and ai). In contrast ⫹/⫺
MEFs from hetereozygotes (Figure 9B, b), and more notably
homozygous ⫺/⫺ Weeble MEFs showed significant enlargement of endosomes with the appearance of dilated EEA-1–
decorated rings (Figure 9B, c and ci, arrows). Furthermore,
Rab11-decorated endosomes also demonstrated dilatation in
Weeble ⫺/⫺ MEFs (Figure 9B, g and gi, arrows) that was not
detected in the wild-type MEFs (Figure 9B, e and ei). These
studies strongly indicate that the 4-phosphatase generates a
functional PtdIns(3)P pool on endosomes.
4-Phosphatase Regulates the PM Recruitment of the
TAPP1 PH Domain
The 4-phosphatase regulation of the recruitment of
PtdIns(3,4)P2-specific effectors to the PM has not been re2229
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Figure 10. 4-Phosphatase regulates the PM recruitment of a PtdIns(3,4)P2-specific effector. COS-1 cells transiently expressing GFP-TAPP1
PH domain and FLAG empty vector (A) or FLAG-4-phosphatase (B) or HA-4-phosphatase catalytic domain (aa 608 –938) (C). Cells were
serum-starved overnight and stimulated with 100 ng/ml EGF and visualized by confocal microscopy. Cells were scored for TAPP1 PM
localization. Data are expressed as the mean number of cells ⫾ SEM (n ⱖ 3) showing no (white bars), moderate (gray bars), or extensive (black
bars) GFP-PH-TAPP1 PM staining (20 cells scored for each of three independent transfections).
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ported previously. To address this question, we examined
the effect of overexpression of the intact 4-phosphatase versus the isolated catalytic domain on the PM recruitment of
the PH-domain of TAPP1 (GFP-PH-TAPP1), upon EGF stimulation (Figure 10). Cotransfected cells from three independent transfections were scored for extensive, moderate or
absent PM GFP-PH-TAPP1. In serum-starved cells expressing empty FLAG-vector and GFP-PH-TAPP1, GFP fluorescence was detected diffusely throughout the cytoplasm and
the nucleus (Figure 10A). On EGF stimulation, GFP-PHTAPP1 PM staining was evident within 5 min, persisting up
to 45 min (Marshall et al., 2002) (Figure 10A, arrowheads).
After 10 min EGF stimulation, the majority of cells showed
extensive PM staining. By 45 min, the intensity of PM staining had decreased. Significantly, upon coexpression of GFPPH-TAPP1 with wild-type FLAG-4-phosphatase, no PM
GFP fluorescence was detected after 5- to 10-min EGF stimulation (Figure 10B). In some cells, faint PM fluorescence
was evident by 20 and 45 min EGF stimulation, but this was
significantly reduced relative to the empty vector-expressing
cells. As described here, the 4-phosphatase mutants lacking
C2 domains can bind PtdIns(3,4)P2, but they do not possess
PtdIns(3,4)P2 4-phosphatase activity (Figure 6). The isolated
catalytic domain which lacks the C2 domains (HA-catalytic)
was coexpressed with GFP-PH-TAPP1 (Figure 10C). After 10min EGF stimulation, moderate-to-extensive GFP-PH-TAPP1
fluorescence was detected at the PM in the majority of cells
(Figure 10C, arrows). Therefore, the C2AB domain is essential
for 4-phosphatase catalytic activity and thereby regulates the
PM recruitment of PtdIns(3,4)P2-specific PH domains.
DISCUSSION
The results of this study have revealed that the type I
4-phosphatase localizes to early and recycling endosomes
and generates an endosomal pool of PtdIns(3)P, via hydrolysis of PtdIns(3,4)P2. After EGF-stimulated PI 3-kinase activation, the 4-phosphatase translocates to membrane ruffles,
the site of PtdIns(3,4,5)P3 and PtdIns(3,4)P2 synthesis, where
the enzyme inhibits the PM recruitment of the PtdIns(3,4)P2specific TAPP1 PH domain. The 4-phosphatase C2 domains
are critical for the enzyme’s endosomal targeting,
PtdIns(3,4)P2 4-phosphatase catalytic activity, and in agonist-stimulated cells, 4-phosphatase-mediated inhibition of
PM recruitment of TAPP1 PH domain. Collectively, these
studies demonstrate a functional role for the 4-phosphatase
in regulating PI 3-kinase signaling events, both in the endosomal pathway and at the PM.
The spatiotemporal dynamics of membrane trafficking
events are governed by reversible recruitment of effector
proteins to restricted intracellular membranes decorated
with phosphoinositide signals such as PtdIns(3)P and
PtdIns(3,4)P2 (Cantley, 2002; Czech, 2003). Molecular mechanisms mediating the concentration of such lipid signaling
molecules to specific microdomains of intracellular compartmental membranes are in turn regulated by the subcellular
targeting of the specific kinases and/or phosphatases that
respectively synthesize or degrade these phosphoinositides.
Consistent with the contention that PtdIns(3)P and/or
PtdIns(3,4)P2 signals are turned over at high rates in restricted locations, we have shown here that the type I
4-phosphatase localizes to endosomal membranes, colocalizing with early and/or recycling endosomes. Although the
4-phosphatase failed to demonstrate complete colocalization
with early endosomal markers such as EEA-1 or the recycling endosomal marker Rab11, extensive colocalization
with these markers was shown upon coexpression with
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Rab5Q79L or Rab11Q70L. Furthermore, the lack of complete
colocalization between 4-phosphatase and the endosomal
marker EEA-1, is consistent with recent studies showing that
PtdIns(3)P exists on endosomal membrane microdomains,
associated with specific binding proteins. For example, Hrs,
which binds PtdIns(3)P, does not show complete colocalization with EEA-1 (Gillooly et al., 2003). Although cells overexpressing the 4-phosphatase showed some perinuclear
staining, little evidence was demonstrated that this enzyme
localizes to the Golgi, because the enzyme did not consistently colocalize with Golgi markers.
PtdIns(3)P promotes the association of EEA-1 with early
endosomes (Stenmark et al., 1996). The PI 3-kinase inhibitor
wortmannin inhibits the synthesis of PtdIns(3)P, resulting in
enlarged endosomes. (Simonsen et al., 2001). Because wortmannin inhibits both class I and III PI 3-kinases, which
synthesize PtdIns(3)P, PtdIns(3,4)P2, PtdIns(3,4,5)P3, and
PtdIns(3,5)P2, dissection of the trafficking pathways regulated by each specific phosphoinositide has not been directly
evaluated. We have provided evidence here that 4-phosphatase hydrolysis of PtdIns(3,4)P2 generates a functional pool
of PtdIns(3)P. In agonist-stimulated cells, conditions resulting in PtdIns(3,4)P2 synthesis, cells overexpressing the
4-phosphatase showed increased total cellular levels of
PtdIns(3)P. Also, serum-stimulated but not serum-starved
cells overexpressing the 4-phosphatase were resistant to wortmannin-induced endosomal dilatation. Finally, MEFs from
4-phosphatase– deficient mice exhibited endosomal enlargement, reminiscent of that seen in wortmannin-treated cells.
Recent studies using antibodies to class I and III PI 3-kinases demonstrated that the wortmannin-sensitive PI 3-kinases cannot account for all the endosomal PtdIns(3)P, suggesting that the wortmannin-insensitive class II PI 3-kinases
may synthesize a PtdIns(3)P pool that maintains membrane
transport (Tuma et al., 2001a). The studies reported here
support this hypothesis and furthermore indicate that a
functional PtdIns(3)P pool can be generated via 4-phosphatase hydrolysis of PtdIns(3,4)P2. In addition, it is an intriguing possibility that hVPS34 and the 4-phosphatase may generate distinct endosomal PtdIns(3)P pools. The functional
analysis of endosomal trafficking in Weeble ⫺/⫺ MEFs may
provide further evidence of the specific roles PtdIns(3,4)P2
and the 4-phosphatase-generated PtdIns(3)P play in membrane transport and is the subject of ongoing laboratory
investigation. The intracellular localization or function of the
type II 4-phosphatase has not been reported, but given we
have shown defects in endosomal morphology in Weeble
MEFs, these two 4-phosphatases are likely to play nonredundant roles in distinct subcellular locations.
We have shown here that the 4-phosphatase tandem C2
domain binds PtdIns(3,4)P2 and plays a significant role in
directing 4-phosphatase to endosomes in quiescent cells.
However, we cannot exclude the possibility that the C2AB
domain mediates 4-phosphatase endosomal association via
protein–protein rather than protein–phosphoinositide interaction, as has been shown for other C2 domains (Hurley and
Meyer, 2001; Bai and Chapman, 2004). The C2AB domain
also was critical for 4-phosphatase catalytic activity, as
shown by in vitro enzyme assays. In addition, the wild-type
4-phosphatase, but not mutants lacking the C2AB domain,
inhibited the PtdIns(3,4)P2-dependent translocation of PH
domain of TAPP1 to the PM, consistent with a significant
functional role for the C2 domains in facilitating either
PtdIns(3,4)P2 binding and/or orientation with respect to the
catalytic domain. Studies of the lipid phosphatase PTEN,
which also uses PtdIns(3,4)P2 as a substrate and contains an
N-terminal C2 domain, have revealed that both its phospha2231
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tase domain and C2 domain are involved in electrostatic
membrane binding (Das et al., 2003). Like PTEN, we have
shown that the 4-phosphatase catalytic domain and the C2
domains both facilitate membrane binding, the C2 domain
being necessary and sufficient for endosomal membrane
association and the catalytic domain mediating the enzyme’s
association with the PM.
PtdIns(3,4)P2 functions as a signaling molecule in growth
factor-stimulated pathways and also is generated independently of PtdIns(3,4,5)P3 in response to oxidative stress (Van
der Kaay et al., 1999). The major metabolic pathway for
PtdIns(3,4)P2 synthesis in growth factor-stimulated cells is
via 5-phosphatase hydrolysis of PtdIns(3,4,5)P3. It is noteworthy that several PtdIns(3,4,5)P3 5-phosphatases localize
to membrane ruffles in stimulated cells (Dyson et al., 2001;
Gurung et al., 2003). In addition, the TAPP1 PH domain
specifically binds PtdIns(3,4)P2 and also localizes to membrane ruffles, suggesting that this is the site of PtdIns(3,4)P2
synthesis (Marshall et al., 2002). We have shown that upon
EGF-stimulation, the 4-phosphatase translocates to membrane ruffles, where the enzyme regulates the PM recruitment of the PH domain of TAPP1. The targeting of 4-phosphatase to endosomes in quiescent cells, away from the PM,
and its delayed recruitment to membrane ruffles upon agonist stimulation may represent a molecular mechanism mediating delayed and sustained PtdIns(3,4)P2 signaling at the
PM.
A widely accepted concept in the field is that the lipid
phosphatases act to terminate PI 3-kinase signals. However,
with this study we have presented a paradigm shift, showing that the 4-phosphatase also can function in signal generation, forming PtdIns(3)P. In addition, in agonist-stimulated cells, the 4-phosphatase terminates PI 3-kinase signals
at the PM via hydrolysis of PtdIns(3,4)P2 and thereby abrogates the recruitment of its effector proteins to this site.
Therefore, the activity and the subcellular targeting of the
4-phosphatase are critical to its function in both signal generation and termination at specific subcellular sites.
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